跳至主要内容
临床试验/NCT05041114
NCT05041114撤回不适用

Stentrode With Thought-controlled Digital Switch: An Early Feasibility Study of the Safety of an Endovascular Motor Neuroprosthesis in Participants With Severe Upper Limb Impairment.

Synchron Medical, Inc.4 个研究点 分布在 1 个国家开始时间: 2022年4月21日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
4
主要终点
Treatment related adverse events

研究概览

简要总结

The Synchron Motor Neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative therapy and a persistent functioning motor cortex. The purpose of this research is to evaluate safety and feasibility.

The MNP is a type of implantable brain computer interface which bypasses dysfunctional motor neurons. The device is designed to restore the transmission of neural signal from the cerebral cortex utilized for neuromuscular control of digital devices, resulting in a successful execution of non-mechanical digital commands.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe motor impairment
  • Able to give consent
  • Appropriate candidate for neurointerventional procedure
  • Able and willing to access all clinical testing and not impeded by geographical location
  • Proficient in English
  • Have a study partner

排除标准

  • Active condition resulting in immunosuppression
  • Unsuitable for general anaesthetic
  • Anaphylactic allergy to contrast media
  • Allergy to nickel
  • History of pulmonary embolism
  • History of recent deep vein thrombosis
  • Psychiatric or psychological disorder
  • No study partner or caregiver
  • Unable to provide evidence of COVID vaccination

结局指标

主要结局

Treatment related adverse events

时间窗: 12 months post implant

次要结局

未报告次要终点

研究者

发起方
Synchron Medical, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验